Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping

BACKGROUND: Vigilant management of women with high-risk human papillomavirus (hrHPV) is necessary in cancer screening programs. To this end, we evaluated the performance of S5 (targeting DNA methylation in HPV16, HPV18, HPV31, HPV33, and human gene EPB41L3) to predict cervical intraepithelial neopla...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Epigenetics
Autors principals: Hernández-López, Rubí, Lorincz, Attila T., Torres-Ibarra, Leticia, Reuter, Caroline, Scibior-Bentkowska, Dorota, Warman, Rhian, Nedjai, Belinda, Mendiola-Pastrana, Indira, León-Maldonado, Leith, Rivera-Paredez, Berenice, Ramírez-Palacios, Paula, Lazcano-Ponce, Eduardo, Cuzick, Jack, Salmerón, Jorge
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790057/
https://ncbi.nlm.nih.gov/pubmed/31606044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-019-0743-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars